Literature DB >> 23925612

Implications of combat casualty care for mass casualty events.

Eric A Elster1, Frank K Butler, Todd E Rasmussen.   

Abstract

Mesh：

Year:  2013        PMID： 23925612     DOI： 10.1001/jama.2013.167481

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  7 in total

1.  Adipose-derived stromal cells promote allograft tolerance induction.

Authors:  Thomas A Davis; Khairul Anam; Yelena Lazdun; Jeffrey M Gimble; Eric A Elster
Journal:  Stem Cells Transl Med       Date:  2014-11-19       Impact factor: 6.940

2.  Response to COVID-19 by the surgical community.

Authors:  Eric Elster; Benjamin K Potter; Kevin Chung
Journal:  Surgery       Date:  2020-03-31       Impact factor: 3.982

3.  Delivering patient care during large-scale emergency situations: Lessons from military care providers.

Authors:  Lara Varpio; Karlen Bader-Larsen; Meghan Hamwey; Steven Durning; Holly Meyer; Danette Cruthirds; Anthony Artino
Journal:  PLoS One       Date:  2021-03-31       Impact factor: 3.240

4.  Lessons of War: Turning Data Into Decisions.

Authors:  Jonathan A Forsberg; Benjamin K Potter; Matthew B Wagner; Andrew Vickers; Christopher J Dente; Allan D Kirk; Eric A Elster
Journal:  EBioMedicine       Date:  2015-07-17       Impact factor: 8.143

Review 5.  Pre-hospital management of mass casualty civilian shootings: a systematic literature review.

Authors:  Conor D A Turner; David J Lockey; Marius Rehn
Journal:  Crit Care       Date:  2016-11-08       Impact factor: 9.097

6.  Response to mass casualty events: from the battlefield to the Stop the Bleed campaign.

Authors:  M Margaret Knudson; George Velmahos; Zara R Cooper
Journal:  Trauma Surg Acute Care Open       Date:  2016-07-07

7.  Understanding risks, mitigation and innovation for surgery in a COVID-19 world.

Authors:  M Birchall; J Blazeby; N Blencowe; J Donovan; D Elliott; M Jepson; P Hutchinson; D Jayne; A Skilton
Journal:  Br J Surg       Date:  2020-05-15       Impact factor: 6.939
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.